References
- Lundin KE, Qiao SW, Snir O, Sollid LM. Coeliac disease - from genetic and immunological studies to clinical applications. Scand J Gastroenterol 2015;50:708-17. https://doi.org/10.3109/00365521.2015.1030766
- Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 2012;19:88. https://doi.org/10.1186/1423-0127-19-88
- Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med 2019;17:142. https://doi.org/10.1186/s12916-019-1380-z
- Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012;18:6036-59. https://doi.org/10.3748/wjg.v18.i42.6036
- Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:823-36.e2. https://doi.org/10.1016/j.cgh.2017.06.037
- Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012;107:1538-44; quiz 1537, 1545. https://doi.org/10.1038/ajg.2012.219
- Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 2003;98:377-81. https://doi.org/10.1016/S0002-9270(02)05906-3
- Castro-Antunes MM, Crovella S, Brandao LA, Guimaraes RL, Motta ME, Silva GA. Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil. Clinics (Sao Paulo) 2011;66:227-31. https://doi.org/10.1590/S1807-59322011000200008
- Akirov A, Pinhas-Hamiel O. Co-occurrence of type 1 diabetes mellitus and celiac disease. World J Diabetes 2015;6:707-14. https://doi.org/10.4239/wjd.v6.i5.707
- Not T, Tommasini A, Tonini G, Buratti E, Pocecco M, Tortul C, et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001;44:151-5. https://doi.org/10.1007/s001250051593
- Holmes GK. Screening for coeliac disease in type 1 diabetes. Arch Dis Child 2002;87:495-8. https://doi.org/10.1136/adc.87.6.495
- Holmes GK. Coeliac disease and Type 1 diabetes mellitus - the case for screening. Diabet Med 2001;18:169-77. https://doi.org/10.1046/j.1464-5491.2001.00498.x
- Caja S, Maki M, Kaukinen K, Lindfors K. Antibodies in celiac disease: implications beyond diagnostics. Cell Mol Immunol 2011;8:103-9. https://doi.org/10.1038/cmi.2010.65
- Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S38-46. https://doi.org/10.1053/j.gastro.2005.02.028
- Arigliani M, Rech Morassutti F, Fabris M, Melli P, Tonutti E, Cogo P. Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! Ital J Pediatr 2017;43:70. https://doi.org/10.1186/s13052-017-0392-6
- Lammi A, Arikoski P, Hakulinen A, Schwab U, Uusitupa M, Heinonen S, et al. Development of gliadinspecific immune responses in children with HLA-associated genetic risk for celiac disease. Scand J Gastroenterol 2016;51:168-77. https://doi.org/10.3109/00365521.2015.1067328
- Basso D, Guariso G, Bozzato D, Rossi E, Pescarin M, Fogar P, et al. New screening tests enrich antitransglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. Clin Chim Acta 2011;412:1662-7. https://doi.org/10.1016/j.cca.2011.05.024
- Lagerqvist C, Dahlbom I, Hansson T, Jidell E, Juto P, Olcen P, et al. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age. J Pediatr Gastroenterol Nutr 2008;47:428-35. https://doi.org/10.1097/MPG.0b013e31817d80f4
- Mozo L, Gomez J, Escanlar E, Bousono C, Gutierrez C. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J Pediatr Gastroenterol Nutr 2012;55:50-5. https://doi.org/10.1097/MPG.0b013e31824703c7
- Sakly W, Mankai A, Ghdess A, Achour A, Thabet Y, Ghedira I. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis. Clin Res Hepatol Gastroenterol 2012;36:598-603. https://doi.org/10.1016/j.clinre.2012.01.008
- Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010;44:186-90. https://doi.org/10.1097/MCG.0b013e3181c378f6
- Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol 2009;9:57. https://doi.org/10.1186/1471-230X-9-57
- Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 2011;45:673-8. https://doi.org/10.1097/MCG.0b013e3181fbdfa6
- Tsouka A, Mahmud FH, Marcon MA. Celiac disease alone and associated with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2015;61:297-302. https://doi.org/10.1097/MPG.0000000000000789
- Pall H, Newhook LA, Aaron H, Curtis J, Randell E. Young age at diagnosis of type 1 diabetes is associated with the development of celiac disease-associated antibodies in children living in Newfoundland and Labrador, Canada. Children (Basel) 2015;2:403-11. https://doi.org/10.3390/children2040403
- Castellaneta S, Piccinno E, Oliva M, Cristofori F, Vendemiale M, Ortolani F, et al. High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study. Diabetes Care 2015;38:760-6. https://doi.org/10.2337/dc14-2890
- Chan AW, Butzner JD, McKenna R, Fritzler MJ. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics 2001;107:E8. https://doi.org/10.1542/peds.107.1.e8
- Matteucci E, Cinapri V, Quilici S, Lucchetti A, Mugnaini P, Giampietro O. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers. Diabetes Nutr Metab 2001;14:37-42.
- Waisbourd-Zinman O, Hojsak I, Rosenbach Y, Mozer-Glassberg Y, Shalitin S, Phillip M, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci 2012;57:1314-20. https://doi.org/10.1007/s10620-011-2016-0
- Rinawi F, Badarneh B, Tanous O, Bashir H, Tennenbaum-Rakover Y, Peleg S. Elevated anti-tissue transglutaminase antibodies in children newly diagnosed with type 1 diabetes do not always indicate coeliac disease. Acta Paediatr 2019;108:149-53. https://doi.org/10.1111/apa.14398
- Liu E, Bao F, Barriga K, Miao D, Yu L, Erlich HA, et al. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol 2003;1:356-62. https://doi.org/10.1053/S1542-3565(03)00180-0
- Hagopian W, Lee HS, Liu E, Rewers M, She JX, Ziegler AG, et al.TEDDY Study Group. Co-occurrence of type 1 diabetes and celiac disease autoimmunity. Pediatrics 2017;140:e20171305. https://doi.org/10.1542/peds.2017-1305
- Maglio M, Florian F, Vecchiet M, Auricchio R, Paparo F, Spadaro R, et al. Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. Diabetes 2009;58:1578-84. https://doi.org/10.2337/db08-0962
- Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52. https://doi.org/10.1136/gutjnl-2011-301346
- Boyd JC. Defining laboratory reference values and decision limits: populations, intervals, and interpretations. Asian J Androl 2010;12:83-90. https://doi.org/10.1038/aja.2009.9